IP Library › Granted Patent US 12,341,619
Granted Patent B2
US 12,341,619 · App. 18/204,873 · Granted Jun 24, 2025

User interface for content moderation of voice chat

Inventors: William Carter Huffman (Cambridge, MA); Michael Pappas (Cambridge, MA); Ken Morino (Acton, MA); David Pickart (Chicago, IL)
Assignee: Modulate, Inc.
H04L12/1822G06F3/0482G06F3/0484G10L15/08G10L25/27G10L25/63H04L65/403
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,341,619
App. No.
18/204,873
Granted
Jun 24, 2025
Kind
B2
Abstract

A content moderation system analyzes speech, or characteristics thereof, and determines a toxicity score representing the likelihood that a given clip of speech is toxic. A user interface displays a timeline with various instances of toxicity by one or more users for a give session. The user interface is optimized for moderation interaction, and shows how the conversation containing toxicity evolves over the time domain of a conversation.

Claims (41)

1. A computer-implemented method for displaying toxicity information within a timeline window of a graphical user interface, the method comprising:

calculating a toxicity score for a plurality of speech segments over the course of an audio chat session;

displaying a detailed session timeline showing a plurality of users in at least a portion of an audio chat session in a user interface, the detailed session timeline including a time axis having one or more toxicity indicators that represent a severity of toxicity and correspond to a given user.

2. The method of claim 1 , wherein each of the plurality of users has a time axis simultaneously displayed in the timeline.

3. The method of claim 2 , wherein each of the independent time axes is a horizontal axis.

4. The method of claim 2 , wherein each of the independent time axes displays a speech indicator that represents a time when the corresponding user is speaking.

5. The method of claim 2 , wherein each of the independent time axes has a session start time indicator and a session end time indicator for the user.

6. The method of claim 2 , wherein each of the independent time axes has a user indicator.

7. The method of claim 1 , wherein the toxicity indicator includes a toxicity score for the speech segment.

8. The method of claim 1 , wherein the toxicity indicators provide a heatmap for toxicity scores.

9. The method of claim 1 , wherein a moderator may select a user view for a particular user.

10. The method of claim 1 , wherein the length of the one or more vertical toxicity indicators is a function of a toxicity score.

11. The method of claim 1 , wherein selecting a toxicity indicator displays a transcript and audio file for the associated speech segment within the user interface.

12. The method of claim 1 , further comprising display an entire session timeline window showing the entire audio chat session.

13. The method of claim 12 , further comprising selecting a portion for the detailed session timeline window from the entire session timeline window; and

displaying the selected portion in the detailed session timeline window.

14. The method of claim 13 , further comprising selecting a different portion for the detailed session timeline window from the entire session timeline window; and

displaying the different portion in the detailed session timeline window.

15. The method of claim 1 , further comprising displaying a session details window, the session details window including a speaker identification, a number of speaker offenses for the speaker, a max toxicity score for the speaker, and a classification of offenses for the speaker during the session.

16. The method of claim 15 , wherein a moderator selection of the speaker identification causes the graphical user interface to display a user view with a window with showing all of the selected user's activity.

17. The method of claim 16 , wherein the user view displays the length of each session for the user, the maximum toxicity for the user for each session, and the offense category for each session.

18. The method of claim 1 , further comprising selected a portion of the detailed timeline view.

19. The method of claim 1 , further comprising displaying toxicity indicators for toxicity that meets a toxicity score threshold.

20. The method of claim 1 , further comprising receiving an input in the detailed session timeline window, the input corresponding to an interval of time; and

displaying a transcription of toxic speech that meets a toxicity score threshold for the corresponding interval of time.

21. The method of claim 20 , further comprising displaying a link to audio for the toxic speech for the corresponding interval of time.

22. The method of claim 1 , further comprising displaying toxicity indicators for a plurality of users.

23. The method of claim 1 , wherein the horizontal time axis has a thickness along its length that is a function of an amount of speech.

24. The method of claim 1 , further comprising display a moderator action window.

25. The method of claim 24 , wherein the moderator action window includes options for muting, suspending, or banning the speaker.

26. A multi-stage content analysis system comprising:

a first stage trained using a database having training data with positive and/or negative examples of training content for the first stage,

the first stage configured to:

receive speech content,

analyze the speech content to categorize the speech content as having first-stage positive speech content and/or first-stage negative speech content;

a subsequent stage configured to receive at least a portion, but less than all, of the first-stage negative speech content,

the subsequent stage further configured to analyze the first-stage positive speech content to categorize the first-stage positive speech content as having subsequent-stage positive speech content and/or subsequent-stage negative speech content, the subsequent stage further configured to update the database using the subsequent-stage positive speech content and/or the subsequent-stage negative speech content,

the subsequent stage including a toxicity scorer configured to provide a toxicity score for subsequent-stage positive speech content;

a user interface configured to display the toxicity score for the subsequent-stage positive speech content.

27. The multi-stage content analysis system of claim 26 , wherein the user interface is configured to display the toxicity score for multiple users within a timeline.

28. The multi-stage content analysis system of claim 27 , wherein each of the toxicity scores for the multiple users includes a toxicity indicator and an associated user indicator within the timeline.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2024
From: HUFFMAN, WILLIAM CARTER; PAPPAS, MICHAEL; MORINO, KEN; PICKART, DAVID
To: MODULATE, INC.
Reel/Frame 066278/0886 →
Continuity (3)
Provisional Application 63347948 · Jun 1, 2022
Provisional Application 63347947 · Jun 1, 2022
Related Publication 20230396457A1 · Dec 7, 2023
References Cited (279)
US 3610831A · Moshier · 1971 [cited by applicant]
US 5327521A · Savic et al. · 1994 [cited by applicant]
US 5677989A · Rabin et al. · 1997 [cited by applicant]
US 5704006A · Iwahashi · 1997 [cited by applicant]
US 5749066A · Nussbaum · 1998 [cited by applicant]
US 5758023A · Bordeaux · 1998 [cited by applicant]
US 5808222A · Yang · 1998 [cited by applicant]
US 6161091A · Akamine et al. · 2000 [cited by applicant]
US 6307140B1 · Iwamoto · 2001 [cited by applicant]
US 6336092B1 · Gibson et al. · 2002 [cited by applicant]
US 7117154B2 · Yoshioka et al. · 2006 [cited by applicant]
US 7412377B2 · Monkowski · 2008 [cited by applicant]
US 7565697B2 · LeVine et al. · 2009 [cited by applicant]
US 7590532B2 · Suzuki et al. · 2009 [cited by applicant]
US 7634399B2 · Hardwick · 2009 [cited by applicant]
US 7634410B2 · Lemoine et al. · 2009 [cited by applicant]
US 7664645B2 · Hain et al. · 2010 [cited by applicant]
US 7881944B2 · Heller et al. · 2011 [cited by applicant]
US 7987244B1 · Lewis et al. · 2011 [cited by applicant]
US 8060565B1 · Swartz · 2011 [cited by applicant]
US 8121845B2 · Kirby · 2012 [cited by applicant]
US 8131550B2 · Nurminen et al. · 2012 [cited by applicant]
US 8156518B2 · O'Hern · 2012 [cited by applicant]
US 8290772B1 · Cohen et al. · 2012 [cited by applicant]
US 8473281B2 · Maude et al. · 2013 [cited by applicant]
US 8655659B2 · Wang et al. · 2014 [cited by applicant]
US 8930183B2 · Chun et al. · 2015 [cited by applicant]
US 9009052B2 · Nakano et al. · 2015 [cited by applicant]
US 9135923B1 · Chen · 2015 [cited by applicant]
US 9148630B2 · Morris et al. · 2015 [cited by applicant]
US 9153235B2 · Zhang et al. · 2015 [cited by applicant]
US 9183830B2 · Agiomyrgiannakis · 2015 [cited by applicant]
US 9305530B1 · Durham et al. · 2016 [cited by applicant]
US 9532136B2 · Uhle et al. · 2016 [cited by applicant]
US 9589574B1 · Klimanis et al. · 2017 [cited by applicant]
US 9591427B1 · Lyren et al. · 2017 [cited by applicant]
US 9800721B2 · Gainsboro et al. · 2017 [cited by applicant]
US 10046237B2 · Rom et al. · 2018 [cited by applicant]
US 10186251B1 · Mohammadi · 2019 [cited by applicant]
US 10198667B2 · Ryan, Jr. et al. · 2019 [cited by applicant]
US 10357713B1 · Landers et al. · 2019 [cited by applicant]
US 10361673B1 · Matsukawa · 2019 [cited by applicant]
US 10453476B1 · Aryal · 2019 [cited by applicant]
US 10614826B2 · Huffman et al. · 2020 [cited by applicant]
US 10622002B2 · Huffman et al. · 2020 [cited by applicant]
US 10706839B1 · Stephenson · 2020 [cited by applicant]
US 10706867B1 · Villavicencio et al. · 2020 [cited by applicant]
US 10708687B1 · Gedney et al. · 2020 [cited by applicant]
US 10807006B1 · Davis et al. · 2020 [cited by applicant]
US 10912989B2 · Kornmann et al. · 2021 [cited by applicant]
US 10918956B2 · Rout et al. · 2021 [cited by applicant]
US 10922534B2 · Zavesky et al. · 2021 [cited by applicant]
US 10936817B2 · Agarwal et al. · 2021 [cited by applicant]
US 10940396B2 · Pinto et al. · 2021 [cited by applicant]
US 10987592B1 · Schaeppi et al. · 2021 [cited by applicant]
US 10994209B2 · Miyaki · 2021 [cited by applicant]
US 10997494B1 · Ng et al. · 2021 [cited by applicant]
US 11010687B2 · Mehdad et al. · 2021 [cited by applicant]
US 11017788B2 · Huffman et al. · 2021 [cited by applicant]
US 11056131B2 · Kulavik et al. · 2021 [cited by applicant]
US 11090566B1 · Chow · 2021 [cited by applicant]
US 11170800B2 · McAlpine et al. · 2021 [cited by applicant]
US 11235248B1 · Orrino et al. · 2022 [cited by applicant]
US 11266912B2 · Dorn et al. · 2022 [cited by applicant]
US 11278815B2 · Kulavik et al. · 2022 [cited by applicant]
US 11358066B2 · Hume et al. · 2022 [cited by applicant]
US 11538485B2 · Huffman et al. · 2022 [cited by applicant]
US 11714967B1 · Wu et al. · 2023 [cited by applicant]
US 11854563B2 · Huffman et al. · 2023 [cited by applicant]
US 11996117B2 · Huffman · 2024 [cited by examiner]
US 20010044721A1 · Yoshioka et al. · 2001 [cited by applicant]
US 20020046899A1 · Mizuno et al. · 2002 [cited by applicant]
US 20020072900A1 · Keough et al. · 2002 [cited by applicant]
US 20020086653A1 · Kim · 2002 [cited by applicant]
US 20020116641A1 · Mastrianni · 2002 [cited by applicant]
US 20020120854A1 · LeVine et al. · 2002 [cited by applicant]
US 20030135374A1 · Hardwick · 2003 [cited by applicant]
US 20030154080A1 · Godsey et al. · 2003 [cited by applicant]
US 20030158734A1 · Cruickshank · 2003 [cited by applicant]
US 20040010798A1 · Galli et al. · 2004 [cited by applicant]
US 20040112203A1 · Ueki et al. · 2004 [cited by applicant]
US 20050064374A1 · Spector · 2005 [cited by applicant]
US 20050108227A1 · Russell-Falla et al. · 2005 [cited by applicant]
US 20050131680A1 · Chazan et al. · 2005 [cited by applicant]
US 20060003305A1 · Kelmar · 2006 [cited by applicant]
US 20060095262A1 · Danieli · 2006 [cited by applicant]
US 20060210956A1 · Okamoto · 2006 [cited by applicant]
US 20060268007A1 · Gopalakrishnan · 2006 [cited by applicant]
US 20070112568A1 · Fingscheidt et al. · 2007 [cited by applicant]
US 20080034231A1 · Ginter et al. · 2008 [cited by applicant]
US 20080082320A1 · Popa et al. · 2008 [cited by applicant]
US 20080177834A1 · Gruhl et al. · 2008 [cited by applicant]
US 20080201150A1 · Tamura et al. · 2008 [cited by applicant]
US 20080221882A1 · Bundock et al. · 2008 [cited by applicant]
US 20080243511A1 · Fujita et al. · 2008 [cited by applicant]
US 20080255830A1 · Rosec et al. · 2008 [cited by applicant]
US 20080262838A1 · Nurminen et al. · 2008 [cited by applicant]
US 20080269633A1 · Watson · 2008 [cited by applicant]
US 20090034704A1 · Ashbrook et al. · 2009 [cited by applicant]
US 20090037179A1 · Liu et al. · 2009 [cited by applicant]
US 20090055189A1 · Stuart et al. · 2009 [cited by applicant]
US 20090089063A1 · Meng et al. · 2009 [cited by applicant]
US 20090094027A1 · Nurminen et al. · 2009 [cited by applicant]
US 20090177473A1 · Aaron et al. · 2009 [cited by applicant]
US 20090216528A1 · Gemello et al. · 2009 [cited by applicant]
US 20100049522A1 · Tamura et al. · 2010 [cited by applicant]
US 20100082326A1 · Bangalore et al. · 2010 [cited by applicant]
US 20100088089A1 · Hardwick · 2010 [cited by applicant]
US 20100094620A1 · Hardwick · 2010 [cited by applicant]
US 20100198600A1 · Masuda · 2010 [cited by applicant]
US 20100215289A1 · Pradeep et al. · 2010 [cited by applicant]
US 20110098029A1 · Rhoads et al. · 2011 [cited by applicant]
US 20110125493A1 · Hirose et al. · 2011 [cited by applicant]
US 20110161348A1 · Oron · 2011 [cited by applicant]
US 20110191105A1 · Spears · 2011 [cited by applicant]
US 20110218804A1 · Chun · 2011 [cited by applicant]
US 20120095762A1 · Eom et al. · 2012 [cited by applicant]
US 20120095767A1 · Hirose et al. · 2012 [cited by applicant]
US 20120116756A1 · Kalinli · 2012 [cited by applicant]
US 20120166187A1 · Van Buskirk et al. · 2012 [cited by applicant]
US 20120253794A1 · Chun et al. · 2012 [cited by applicant]
US 20120253812A1 · Kalinli et al. · 2012 [cited by applicant]
US 20130025437A1 · Serletic et al. · 2013 [cited by applicant]
US 20130080164A1 · Zanolin et al. · 2013 [cited by applicant]
US 20130144603A1 · Lord et al. · 2013 [cited by applicant]
US 20130150117A1 · Rodriguez et al. · 2013 [cited by applicant]
US 20130151256A1 · Nakano et al. · 2013 [cited by applicant]
US 20130166274A1 · Fagundes et al. · 2013 [cited by applicant]
US 20130203027A1 · De Villers-Sidani et al. · 2013 [cited by applicant]
US 20130268273A1 · Chen et al. · 2013 [cited by applicant]
US 20130311189A1 · Villavicencio et al. · 2013 [cited by applicant]
US 20140046660A1 · Kamdar · 2014 [cited by applicant]
US 20140074459A1 · Chordia et al. · 2014 [cited by applicant]
US 20140088958A1 · Chen · 2014 [cited by applicant]
US 20140088968A1 · Chen · 2014 [cited by applicant]
US 20140114655A1 · Kalinli-Akbacak · 2014 [cited by applicant]
US 20140122081A1 · Kaszczuk et al. · 2014 [cited by applicant]
US 20140136013A1 · Wolverton et al. · 2014 [cited by applicant]
US 20140136187A1 · Wolverton et al. · 2014 [cited by applicant]
US 20140149112A1 · Kalinli-Akbacak · 2014 [cited by applicant]
US 20140180673A1 · Neuhauser et al. · 2014 [cited by applicant]
US 20140180675A1 · Neuhauser et al. · 2014 [cited by applicant]
US 20140195242A1 · Chen · 2014 [cited by applicant]
US 20140200889A1 · Chen · 2014 [cited by applicant]
US 20140245329A1 · Kato et al. · 2014 [cited by applicant]
US 20140274386A1 · Ault et al. · 2014 [cited by applicant]
US 20150005661A1 · Trammell · 2015 [cited by applicant]
US 20150025892A1 · Lee et al. · 2015 [cited by applicant]
US 20150052594A1 · Liberman et al. · 2015 [cited by applicant]
US 20150058015A1 · Mitsufuji et al. · 2015 [cited by applicant]
US 20150063573A1 · Daly · 2015 [cited by applicant]
US 20150070516A1 · Shoemake et al. · 2015 [cited by applicant]
US 20150127350A1 · Agiomyrgiannakis · 2015 [cited by applicant]
US 20150161753A1 · Blesser · 2015 [cited by applicant]
US 20150255074A1 · Jeong et al. · 2015 [cited by applicant]
US 20150279349A1 · Byron et al. · 2015 [cited by applicant]
US 20150309987A1 · Epstein et al. · 2015 [cited by applicant]
US 20150356967A1 · Byron et al. · 2015 [cited by applicant]
US 20150379752A1 · Li et al. · 2015 [cited by applicant]
US 20160005403A1 · Agiomyrgiannakis et al. · 2016 [cited by applicant]
US 20160027423A1 · Deuel et al. · 2016 [cited by applicant]
US 20160036961A1 · Lee · 2016 [cited by applicant]
US 20160111108A1 · Erdogan et al. · 2016 [cited by applicant]
US 20160196630A1 · Blesser · 2016 [cited by applicant]
US 20160260425A1 · Saino et al. · 2016 [cited by applicant]
US 20160300582A1 · Vaillancourt et al. · 2016 [cited by applicant]
US 20160378427A1 · Sharma et al. · 2016 [cited by applicant]
US 20160379641A1 · Liu et al. · 2016 [cited by applicant]
US 20170018270A1 · Min · 2017 [cited by applicant]
US 20170048176A1 · Onusko et al. · 2017 [cited by applicant]
US 20170125008A1 · Maisonnier et al. · 2017 [cited by applicant]
US 20170133005A1 · Mason · 2017 [cited by applicant]
US 20170142548A1 · Buskirk et al. · 2017 [cited by applicant]
US 20170149961A1 · Kim et al. · 2017 [cited by applicant]
US 20170249953A1 · Yassa et al. · 2017 [cited by applicant]
US 20180040324A1 · Wilberding · 2018 [cited by applicant]
US 20180053261A1 · Hershey · 2018 [cited by applicant]
US 20180097841A1 · Stolarz et al. · 2018 [cited by applicant]
US 20180108370A1 · Dow et al. · 2018 [cited by applicant]
US 20180137875A1 · Liu et al. · 2018 [cited by applicant]
US 20180146370A1 · Krishnaswamy et al. · 2018 [cited by applicant]
US 20180182397A1 · Carbune et al. · 2018 [cited by applicant]
US 20180225083A1 · Barkley et al. · 2018 [cited by applicant]
US 20180276710A1 · Tietzen et al. · 2018 [cited by applicant]
US 20180277113A1 · Hartung et al. · 2018 [cited by applicant]
US 20180316709A1 · Purian · 2018 [cited by applicant]
US 20180336713A1 · Avendano et al. · 2018 [cited by applicant]
US 20180342256A1 · Huffman et al. · 2018 [cited by applicant]
US 20180342257A1 · Huffman et al. · 2018 [cited by applicant]
US 20180342258A1 · Huffman et al. · 2018 [cited by applicant]
US 20190013038A1 · Thomson et al. · 2019 [cited by applicant]
US 20190051276A1 · Lathrop et al. · 2019 [cited by applicant]
US 20190052471A1 · Panattoni et al. · 2019 [cited by applicant]
US 20190364126A1 · Todd · 2019 [cited by applicant]
US 20190378024A1 · Singh et al. · 2019 [cited by applicant]
US 20200005773A1 · Schmidt et al. · 2020 [cited by applicant]
US 20200030971A1 · Oleynik · 2020 [cited by examiner]
US 20200099640A1 · Andre et al. · 2020 [cited by applicant]
US 20200125639A1 · Doyle · 2020 [cited by applicant]
US 20200125928A1 · Doyle · 2020 [cited by applicant]
US 20200129864A1 · Tran et al. · 2020 [cited by applicant]
US 20200142999A1 · Pedersen · 2020 [cited by applicant]
US 20200164278A1 · Andre et al. · 2020 [cited by applicant]
US 20200187841A1 · Ayyad · 2020 [cited by applicant]
US 20200219488A1 · Bender et al. · 2020 [cited by applicant]
US 20200243101A1 · Huffman et al. · 2020 [cited by applicant]
US 20200267165A1 · Leliwa · 2020 [cited by examiner]
US 20200314152A1 · Andre et al. · 2020 [cited by applicant]
US 20200335090A1 · Freed et al. · 2020 [cited by applicant]
US 20210004440A1 · Purnell · 2021 [cited by examiner]
US 20210019339A1 · Ghulati · 2021 [cited by examiner]
US 20210050025A1 · Huffman et al. · 2021 [cited by applicant]
US 20210201893A1 · Lyu et al. · 2021 [cited by applicant]
US 20210224858A1 · Khoury et al. · 2021 [cited by applicant]
US 20210234823A1 · Levkovitz et al. · 2021 [cited by applicant]
US 20210256985A1 · Huffman et al. · 2021 [cited by applicant]
US 20210322887A1 · Schaeppi · 2021 [cited by applicant]
US 20210329124A1 · Li et al. · 2021 [cited by applicant]
US 20210370188A1 · Thomas et al. · 2021 [cited by applicant]
US 20210402304A1 · Dorn et al. · 2021 [cited by applicant]
US 20220008830A1 · Valencia · 2022 [cited by applicant]
US 20220032199A1 · Rudi et al. · 2022 [cited by applicant]
US 20220043982A1 · Purnell · 2022 [cited by examiner]
US 20220059071A1 · Pearce · 2022 [cited by examiner]
US 20220096937A1 · Dorn et al. · 2022 [cited by applicant]
US 20220111297A1 · Rudi et al. · 2022 [cited by applicant]
US 20220115033A1 · Huffman · 2022 [cited by examiner]
US 20220184502A1 · Vogel · 2022 [cited by applicant]
US 20220203244A1 · Ng et al. · 2022 [cited by applicant]
US 20220207421A1 · Fong et al. · 2022 [cited by applicant]
US 20220224792A1 · Horton et al. · 2022 [cited by applicant]
US 20220284884A1 · Tongya · 2022 [cited by applicant]
US 20230016729A1 · Pouran Ben Veyseh et al. · 2023 [cited by applicant]
US 20230245650A1 · Cary · 2023 [cited by examiner]
US 20230321546A1 · Huffman et al. · 2023 [cited by applicant]
US 20230395065A1 · Huffman et al. · 2023 [cited by applicant]
US 20240012864A1 · Siegel et al. · 2024 [cited by applicant]
US 20240119954A1 · Huffman et al. · 2024 [cited by applicant]
US 20240296858A1 · Huffman et al. · 2024 [cited by applicant]
CN 101359473A · 2009 [cited by applicant]
CN 102982809A · 2013 [cited by applicant]
CN 107293289A · 2017 [cited by applicant]
JP 2006319598A · 2006 [cited by applicant]
JP 2009157050A · 2009 [cited by applicant]
JP 2020150409A · 2020 [cited by applicant]
KR 101665882B1 · 2016 [cited by applicant]
KR 101666930B1 · 2016 [cited by applicant]
WO 2017130486A1 · 2017 [cited by applicant]
WO 2018218081A1 · 2018 [cited by applicant]
WO 2020004213A1 · 2020 [cited by applicant]
Anderson F Machado et al: “Voice Conversion: a Critical SURVEYe/pjp”, 20100101, Jan. 1, 2010 (Jan. 1, 2010), pp. 1-8, XP007921050, Retrieved from the Internet: URL:www.ime.usp.br/-mqz/SMC2010Voice.pdf. [cited by applicant]
Arik et al.—“Neural Voice Cloning with a Few Samples,” arXiv:1802.06006 [cs.CL], 17 pages, Mar. 20, 2018. [cited by applicant]
Arjovsky et al.—“Wasserstein GAN,” arXiv:1701.07875 [stat.ML], 32 pages, Dec. 6, 2017. [cited by applicant]
Arora et al., “Real-Time Adaptive Speech Watermarking Scheme for Mobile Applications”, Dec. 18, 2003, retrieved on [Nov. 25, 2020]. Retrieved from the internet URL:https://ieexplore.ieee.org/stamp/stamp.sp?tp=&amumber= … [cited by applicant]
De Brébisson et al.—“Create a digital copy of your voice with one minute of audio,” Lyrebird, https://lyrebird.ai, 1 page showing URL provided, 2017. [cited by applicant]
Desai, S., et al., “Spectral Mapping Using Artificial Neural Networks for Voice Conversion,” IEEE Transactions on Audio, Speech, and Language Processing, vol. 18, No. 5, Jul. 2010, pp. 954-964. [cited by applicant]
Extended European Search Report issued by the European Patent Office for European Patent Application No. 18806567.6, dated Jan. 21, 2022. [cited by applicant]
Goodfellow et al.—“Generative Adversarial Nets,” arXiv:1406.2661 [stat.ML], 9 pages, Jun. 10, 2014. [cited by applicant]
Gulrajani et al.—“Improved Training of Wasserstein GANs,” arXiv:1704.00028 [cs.LG], 20 pages, Dec. 25, 2017. [cited by applicant]
Hong—“RNN GAN Based General Voice Conversion-Pitch,” Youtube, Retrieved from https://www.youtube.com/watch?v=ULWLleBDCEY, 1 page showing URL provided, Jan. 12, 2018. [cited by applicant]
Hsu et al.—“Voice Conversion from Unaligned Corpora using Variational Autoencoding Wasserstein Generative Adversarial Networks,” arXiv:1704.00849 [cs.CL], 5 pages, Jun. 8, 2017. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US23/17930, mailed Aug. 11, 2023, 7 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US23/24193, mailed Oct. 24, 2023, 12 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2018/034485, mailed Sep. 25, 2018, 21 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/046534, dated Jan. 5, 2021, 23 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/054319, dated Feb. 14, 2022, 18 pages. [cited by applicant]
Kaneko et al.—“Parallel-Data-Free Voice Conversion Using Cycle-Consistent Adversarial Networks,” arXiv:1711.11293 [stat.ML], 5 pages, Dec. 20, 2017. [cited by applicant]
Kaneko et al.—“Sequence-to-Sequence Voice Conversion with Similarity Metric Learned Using Generative Adversarial Networks,” Interspeech 2017, pp. 1283-1287, Aug. 2017. [cited by applicant]
Lorenzo-Trueba et al.—“Can we steal your vocal identity from the Internet?: Initial investigation of cloning Obama's voice using GAN, WaveNet and low-quality found data,” arXiv:1803.00860 [eess.AS], 8 pages, Mar. 2, 201… [cited by applicant]
Machado, A., et al. “Voice Conversion: A Critical Survey,” retrieved from https://www.ime.usp.br/˜mqz/SMC2010_Voice.pdf, pp. 291-298, published in 2010. [cited by applicant]
Ming Huaiping et al: “Exemplar-based sparse representation of timbre and prosody for voice conversion”, 2016 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), IEEE, Mar. 20, 2016 (Mar. 2… [cited by applicant]
Mobin et al.—“Voice Conversion using Convolutional Neural Networks,” 2016 Machine Learning Summer School, Abstract, 6 pages (Sep. 2018). [cited by applicant]
Nachmani et al.—“Fitting New Speakers Based on a Short Untranscribed Sample,” arXiv:1802.06984 [cs.LG], 9 pages, Feb. 20, 2018. [cited by applicant]
Oyamada et. al.—“Non-native speech conversion with consistency-aware recursive network and generative adversarial network,” Proceedings of APSIPA Annual Summit and Conference, 7 pages, Dec. 2017. [cited by applicant]
Salimans et al.—“Improved Techniques for Training GANs,” arXiv:1606.03498 [cs.LG], 10 pages, Jun. 10, 2016. [cited by applicant]
Srinivas Desai et al: “Spectral Mapping Using Artificial Neural Networks for Voice Conversion”, IEEE Transactions on Audio, Speech and Language Processing, IEEE, US, vol. 18, No. 5, Jul. 1, 2010 (Jul. 1, 2010), pp. 954-… [cited by applicant]
European Patent Office, Partial Supplementary European Search Report for European Patent Application No. 21878682.0, dated Sep. 10, 2024, 12 pages. [cited by applicant]
Japan Patent Office, Japanese Office Action for Japanese Patent Application No. 2023-547324, dated Dec. 11, 2024, 18 pages. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action, U.S. Appl. No. 18/204,869, dated May 9, 2025 (97 pages). [cited by applicant]
Cited By (1)
US 12,744,687